Holen Sie sich die Stockscreener-App
71.90
0.64%
0.46
Handel nachbörslich:
71.90
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom stock (US2521311074): Insider sale adds focus on shares - AD HOC NEWS
The DexCom Stock Turnaround Is Showing Real Signs of Life - Yahoo Finance
DexCom Inc. stock underperforms Friday when compared to competitors - MSN
Dexcom stock (US2521311074): Insider sale and sharp price jump put CGM specialist in focus - AD HOC NEWS
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany - Zacks Investment Research
Elliott strikes Dexcom board settlement after taking stake - MSN
Devon Energy Corp stock (US2521311074): earnings momentum and oil price tailwinds in focus - AD HOC NEWS
A Look at DexCom Inc (DXCM) After 5.6% Gain -- GF Value $102.05 vs Price $65.09 - GuruFocus
Dexcom Inc. stock (US2521311074): buyback, 2030 targets and activist deal fire up DXCM - AD HOC NEWS
DexCom : Operations and Innovation Committee - marketscreener.com
DexCom, Inc.Common Stock (NQ: DXCM - The Chronicle-Journal
DexCom Is Maintained at Buy by Canaccord Genuity - Moomoo
A Potential Turnaround Stock In Digital Healthcare - Good Money Guide
Here's why you should hold DexCom stock in your portfolio for now - MSN
DexCom (DXCM) Introduces Dexcom Flex for Type 2 Diabetes Patients - GuruFocus
DexCom Price Target Cut to $80.00/Share From $100.00 by B of A Securities - Moomoo
Dexcom stock (US2521311074): Analyst moves follow Elliott deal and new long-term targets - AD HOC NEWS
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany - 01net
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces - GuruFocus
DexCom Stock Jumps As 2030 Targets Ignite Bullish Trading - StocksToTrade
Dexcom Reveals Flex CGM for Type 2 Diabetes Patients - Medical Product Outsourcing
DexCom, Inc. Stock 12‑Month Price Target Cut to $82.28, Implies 34% Upside - TradingView
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo - Yahoo Finance
DexCom Expands CGM Access in Germany With New Dexcom Flex System for Type 2 Diabetes - Moomoo
BofA Securities Adjusts Price Target on DexCom to $80 From $100 - marketscreener.com
DexCom Stock Jumps After Diabetes Management Firm Reaches Agreement With Elliott Investment Management - TIKR.com
DexCom, Inc. (DXCM) Stock Analysis: 33.77% Potential Upside Attracts Investor Attention - DirectorsTalk Interviews
Dexcom Inc. stock (US2521311074): diabetes tech player in focus after recent share move - AD HOC NEWS
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise - MSN
DexCom, Inc. (DXCM) Analyst/Investor DaySlideshow (NASDAQ:DXCM) 2026-05-17 - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
Stephens Investment Management Group LLC Boosts Stock Position in DexCom, Inc. $DXCM - MarketBeat
Assessing DexCom (DXCM) Valuation After Investor Day Targets And New US$1b Buyback Plan - Yahoo Finance
Did New Long-Term Targets and US$1 Billion Buyback Just Shift DexCom's (DXCM) Investment Narrative? - Yahoo Finance
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day - sharewise.com
DexCom Stock Jumps As 2030 Growth Targets And Buybacks Ignite Bullish Momentum - timothysykes.com
DexCom (DXCM) Unveils Ambitious Financial Targets and Share Repu - GuruFocus
Elliott to get two board seats at Dexcom ahead of investor day - MSN
DNB Asset Management AS Boosts Position in DexCom, Inc. $DXCM - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 98,913 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom (DXCM) Posts Upbeat 2026, Climbs 6.6% - Insider Monkey
DexCom Inc (DXCM) Shares Surge 6.6% -- What GF Score of 88 Tells Investors - GuruFocus
What Does Rep. Khanna's Spouse's DXCM Trade Signal for Diabetes Tech - Kavout
Michael Brown reports two 1,700-share DXCM sales through Morgan Stanley (DXCM) - Stock Titan
0.11%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):